Recombinant vaccine cut herpes zoster rate in immunocompromised patientsJuly 9, 2019VaccinesInfectious DiseasesMultiple MyelomaHematologic Malignancies
FDA approves Xpovio for relapsed/refractory multiple myelomaJuly 3, 2019Multiple MyelomaHematologic Malignancies
CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Multiple MyelomaHematologic Malignancies
Similar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Multiple MyelomaRare Diseases
10 Important VA Studies You Might Have Missed at ASHDecember 14, 2018Multiple MyelomaHematologic Malignancies
P-BCMA-101 gains FDA regenerative medicine designationNovember 9, 2018Multiple MyelomaHematologic Malignancies
What’s the Impact of Osteoporosis in Multiple Myeloma?November 8, 2018Multiple MyelomaHematologic Malignancies
